.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
QuintilesIMS
Accenture
Baxter
Teva
Novartis
McKinsey
US Army
Deloitte
Covington

Generated: July 24, 2017

DrugPatentWatch Database Preview

ARAVA Drug Profile

« Back to Dashboard

What is the patent landscape for Arava, and what generic Arava alternatives are available?

Arava is a drug marketed by Sanofi Aventis Us and is included in one NDA.

The generic ingredient in ARAVA is leflunomide. There are six drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the leflunomide profile page.

Summary for Tradename: ARAVA

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list4
Bulk Api Vendors: see list84
Clinical Trials: see list5
Patent Applications: see list5,447
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ARAVA at DailyMed

Pharmacology for Tradename: ARAVA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us
ARAVA
leflunomide
TABLET;ORAL020905-001Sep 10, 1998ABRXYesNo► Subscribe► Subscribe► Subscribe
Sanofi Aventis Us
ARAVA
leflunomide
TABLET;ORAL020905-002Sep 10, 1998ABRXYesYes► Subscribe► Subscribe► Subscribe
Sanofi Aventis Us
ARAVA
leflunomide
TABLET;ORAL020905-003Sep 10, 1998RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ARAVA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us
ARAVA
leflunomide
TABLET;ORAL020905-002Sep 10, 1998► Subscribe► Subscribe
Sanofi Aventis Us
ARAVA
leflunomide
TABLET;ORAL020905-001Sep 10, 1998► Subscribe► Subscribe
Sanofi Aventis Us
ARAVA
leflunomide
TABLET;ORAL020905-001Sep 10, 1998► Subscribe► Subscribe
Sanofi Aventis Us
ARAVA
leflunomide
TABLET;ORAL020905-003Sep 10, 1998► Subscribe► Subscribe
Sanofi Aventis Us
ARAVA
leflunomide
TABLET;ORAL020905-002Sep 10, 1998► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Chubb
Boehringer Ingelheim
Dow
Farmers Insurance
Deloitte
Argus Health
UBS
US Department of Justice
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot